GlassScriptPhysician profile
Sarosh Bukhari
NPI 1306092648
$83,376.74
in general payments reported to CMS, 2019-2025
46 companies · $5,085 in 2025
The $5,085 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,934 · 2021: $13K · 2022: $16K · 2023: $18K · 2024: $11K · 2025: $5,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Food and Beverage: $7,008 · Consulting Fee: $1,200 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,173.00 |
| Food and Beverage | $7,007.99 |
| Consulting Fee | $1,200.00 |
| Education | $115.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $28,584.28 | 2021-2023 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14,406.66 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Phathom Pharmaceuticals, INC. | $12,446.06 | 2024-2025 | Voquezna |
| Abbvie INC. | $7,361.85 | 2019-2025 | Linzess, Rinvoq, Creon |
| Allergan, INC. | $6,122.44 | 2019-2020 | |
| Celgene Corporation | $2,846.30 | 2021-2024 | Zeposia |
| Ironwood Pharmaceuticals, INC | $2,559.04 | 2019-2024 | Linzess |
| Boston Scientific Corporation | $1,466.81 | 2019-2024 | Spyglass, Watchman Flx, Resolution 360 Clip |
| Nestle Healthcare Nutrition INC. | $950.31 | 2020-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $841.06 | 2019-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $687.75 | 2019-2025 | Stelara, Tremfya, Simponi Aria |
| Pharmacosmos Therapeutics INC. | $378.71 | 2023 | Monoferric |
| Janssen Scientific Affairs, LLC | $368.79 | 2020-2024 | Stelara |
| Braintree Laboratories, INC. | $332.61 | 2021-2024 | Sutab, Suflave |
| Merck Sharp & Dohme LLC | $297.65 | 2019-2024 | Dificid, Zinplava |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $284.70 | 2019-2025 | Visiglide |
| Gilead Sciences, INC. | $279.25 | 2019-2025 | |
| Genzyme Corporation | $277.05 | 2022-2025 | |
| Ethicon INC. | $273.31 | 2021-2023 | Monarch Platform |
| Gi Supply, INC. | $267.36 | 2020 | |
| Pfizer INC. | $229.28 | 2019-2025 | |
| Medtronic, INC. | $207.10 | 2022 | |
| Steris Corporation | $204.13 | 2023 | |
| Qol Medical, LLC | $192.52 | 2023-2025 | Sucraid |
| Romark Laboratories, Lc | $187.41 | 2019-2020 | |
| Madrigal Pharmaceuticals | $177.33 | 2025 | Rezdiffra |
| Ethicon US, LLC | $154.62 | 2019 | |
| Sirtex Medical INC | $140.95 | 2019 | |
| Inspire Medical Systems, INC. | $138.64 | 2021 | |
| Sanofi-Aventis U.S. LLC | $125.00 | 2019 | |
| Ardelyx, INC. | $118.89 | 2023-2025 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $110.09 | 2019 | |
| Vivus LLC | $58.81 | 2019-2025 | Pancreaze |
| Ferring Pharmaceuticals INC. | $48.13 | 2019-2020 | |
| Lilly USA, LLC | $44.30 | 2024-2025 | Omvoh |
| Evoke Pharma, INC. | $42.94 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $29.36 | 2024 | Dupixent |
| Novo Nordisk INC | $21.72 | 2025 | Wegovy |
| Celltrion USA INC. | $21.06 | 2025 | Vegzelma |
| Lucid Diagnostics INC. | $19.64 | 2023 | |
| Erbe USA INC | $17.00 | 2023 | Erbe Vio |
| Shionogi INC | $14.32 | 2019 | |
| Shire North American Group INC | $13.82 | 2019 | |
| Ucb, INC. | $13.48 | 2019 | |
| Organon LLC | $9.68 | 2024 | |
| Ambu INC. | $4.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarosh Bukhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.